196 related articles for article (PubMed ID: 6944530)
1. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
[TBL] [Abstract][Full Text] [Related]
2. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
[TBL] [Abstract][Full Text] [Related]
4. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
[TBL] [Abstract][Full Text] [Related]
5. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
6. Regional hyperplastic lymph nodes in breast cancer: the role of lymphocytes and nodal macrophages. An immunological study with a five-year follow-up.
Hickok DF; Miller L; Harris L
Surgery; 1977 Nov; 82(5):710-5. PubMed ID: 199957
[TBL] [Abstract][Full Text] [Related]
7. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
8. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.
Check IJ; Cobb M; Hunter RL
Am J Pathol; 1980 Feb; 98(2):325-38. PubMed ID: 6243870
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
Kadoyama C; Kimura H; Yamaguchi Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
[TBL] [Abstract][Full Text] [Related]
10. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
[TBL] [Abstract][Full Text] [Related]
11. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
Saxon A; Portaro J
Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
Wong PY; Staren ED; Tereshkova N; Braun DP
J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer.
Kadoyama C; Kimura H; Yamaguchi Y
Jpn J Clin Oncol; 1987 Mar; 17(1):29-39. PubMed ID: 2951535
[TBL] [Abstract][Full Text] [Related]
14. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy.
Kurosu Y; Saegusa Y; Tominaga M; Morita K
Jpn J Clin Oncol; 1983 Mar; 13(1):25-30. PubMed ID: 6834651
[TBL] [Abstract][Full Text] [Related]
15. Depression of the generation of cell-mediated cytotoxicity in regional lymph nodes of patients with gastric carcinoma.
Koba F; Akiyoshi T; Tsuji H
J Clin Lab Immunol; 1987 Apr; 22(4):181-4. PubMed ID: 3497276
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
Moritani Y
Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
[TBL] [Abstract][Full Text] [Related]
17. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes.
Vose BM; Vánky F; Argov S; Klein E
Eur J Immunol; 1977 Nov; 7(11):353-7. PubMed ID: 304003
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
[TBL] [Abstract][Full Text] [Related]
20. Stages of the development of immunologic response in regional lymph nodes draining breast cancer.
Kozlowski H; Hrabowska M
Neoplasma; 1978; 25(4):445-52. PubMed ID: 308619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]